Dow Down 0.08% Nasdaq Down 0.35%

More On ACTC

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(ACTC)

-Other OTC
0.00 0.00(0.00%) N/A
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:16.00
Beta:1.42
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:5.00 - 12.73
Volume:0
Avg Vol (3m):N/A
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in .

Headlines

  • No Headlines available for ACTC at this time.

Comparison

Symbol% ChgMkt Cap
ACTC 0.00%N/A
STEMDown 1.91%34.57M
GERNUp 0.96%417.71M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advanced Cell Technology, Inc., a biotechnology company, develops and commercializes human pluripotent stem cell technology in the field of regenerative medicine in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback